| QUVIVIQ Idorsia Pharmaceuticals Ltd 2302317 6 Jul 2022 | Cancelled: Cancelled at the request of IB | Pharmaceutical preparations intended for the prevention or treatment o... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations intended for the prevention or treatment of cardiovascular diseases, hypertension, cerebral haemorrhages and sequela thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergy diseases, autoimmune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, central nervous system diseases and disorders, dementia, insomnia, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage diseases, Fabry disease and Fabry disease symptoms and sequela, infectious diseases and cancer. | |
| QUVIVIQ Idorsia Pharmaceuticals Ltd 2142277 8 Oct 2020 | Protected: Registered/protected | Pharmaceutical preparations for human beings. Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human beings. | |
| QUVIVIQ Idorsia Pharmaceuticals Ltd. 2058395 5 Nov 2019 | Protected: Registered/protected | Pharmaceutical preparations for human beings. Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human beings. | |
| QUVIVIQ Idorsia Pharmaceuticals Ltd 2333651 | Protected: Registered/protected | Pharmaceutical preparations intended for the prevention or treatment o... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations intended for the prevention or treatment of cardiovascular diseases, hypertension, cerebral haemorrhages and sequela thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergy diseases, autoimmune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, central nervous system diseases and disorders, dementia, insomnia, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage diseases, Fabry disease and Fabry disease symptoms and sequela, infectious diseases and cancer. | |
